Since Ozempic blasted onto the stage in 2017 with its approval for type 2 diabetes, drugmakers Novo Nordisk and Eli Lilly have been battling to leapfrog each other with newer and more effective medicines to turbo-charge diabetes and weight-loss results with the class known as GLP-1 receptor agonists. Novo Nordisk’s…
The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss…
Vitamin D and calcium are essential for overall health, but don’t reduce the risk of falls or fractures in…
The US Food and Drug Administration has placed its most serious warning – a so-called black-box warning – on…
A patient in Louisiana has been hospitalized with a severe case of H5N1 bird flu, the US Centers for…
As bird flu infections rise in dairy cattle and chickens, human cases are ticking up too, leaving many people…
Towana Looney is the only person in the world living with a functional pig kidney. But her doctor predicts…